Warning: The NCBI web site requires JavaScript to function. more...
Gene patents and personalized medicine - what lies ahead?
Chandrasekharan S, Cook-Deegan R.
Genome Med. 2009 Sep 28;1(9):92.
Related citations
Impact of gene patents and licensing practices on access to genetic testing for hearing loss.
Chandrasekharan S, Fiffer M.
Genet Med. 2010 Apr;12(4 Suppl):S171-93.
Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
Colaianni A, Chandrasekharan S, Cook-Deegan R.
Genet Med. 2010 Apr;12(4 Suppl):S5-S14.
Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
Chandrasekharan S, Heaney C, James T, Conover C, Cook-Deegan R.
Genet Med. 2010 Apr;12(4 Suppl):S194-211.
Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
Aymé S, Matthijs G, Soini S; ESHG Working Party on Patenting and Licensing.
Eur J Hum Genet. 2008 May;16 Suppl 1:S10-9.
Intellectual property. Enhanced: intellectual property landscape of the human genome.
Jensen K, Murray F.
Science. 2005 Oct 14;310(5746):239-40.
Patenting and licensing in genetic testing.
ESHG Working Party on Patenting and Licensing.
Eur J Hum Genet. 2008 Apr;16(4):405-11. Erratum in: Eur J Hum Genet. 2008 Sep;16(9):1159. Aymé, S [removed]; Matthijs, G [removed]; Soini, S [removed].
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
[No authors listed]
Drugs R D. 2007;8(3):176-87. Review.
Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.
Cook-Deegan R, DeRienzo C, Carbone J, Chandrasekharan S, Heaney C, Conover C.
Genet Med. 2010 Apr;12(4 Suppl):S15-38.
Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.
Chandrasekharan S, Pitlick E, Heaney C, Cook-Deegan R.
Genet Med. 2010 Apr;12(4 Suppl):S155-70.
Gene patents and licensing: case studies prepared for the Secretary's Advisory Committee on Genetics, Health, and Society.
Cook-Deegan R, Heaney C.
Genet Med. 2010 Apr;12(4 Suppl):S1-2.
KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
Bouchard RA.
Health Law J. 2007;15:247-94.
Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.
Skeehan K, Heaney C, Cook-Deegan R.
Genet Med. 2010 Apr;12(4 Suppl):S71-82.
US system of oversight for genetic testing: a report from the Secretary's Advisory Committee on Genetics, Health and Society.
Ferreira-Gonzalez A, Teutsch S, Williams MS, Au SM, Fitzgerald KT, Miller PS, Fomous C.
Per Med. 2008 Sep 1;5(5):521-528.
Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
Abbot J.
J Law Med. 2006 Aug;14(1):110-26.
What are gene patents and why are people worried about them?
Merz JF, Cho MK.
Community Genet. 2005;8(4):203-8.
Balancing innovation and access to healthcare through the patent system--an Australian perspective.
Nicol D.
Community Genet. 2005;8(4):228-34.
Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D. 2005;6(3):178-85. Review.
Legal developments and practical implications of gene patenting on targeted drug discovery and development.
Klein RD.
Clin Pharmacol Ther. 2010 Jun;87(6):633-5.
A brief guide to understanding patentability and the meaning of patents.
Elliott GC.
Acad Med. 2002 Dec;77(12 Pt 2):1309-14. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on